RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCIE SCOPUS

      Efficacy of gastro-retentive forms of ecabet sodium in the treatment of gastric ulcer in rats

      한글로보기

      https://www.riss.kr/link?id=A104666185

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      The purpose of the present study is to investigatethe influence of gastric retention of ecabet sodium(ECS) on its mucoprotective effect in rat ulcer models. Mini-tablets containing 9 mg ECS were prepared using thedirect compression method. The release...

      The purpose of the present study is to investigatethe influence of gastric retention of ecabet sodium(ECS) on its mucoprotective effect in rat ulcer models.
      Mini-tablets containing 9 mg ECS were prepared using thedirect compression method. The release rates of ECS minitabletswere controlled by the amount and viscosity gradeof hydroxypropylmethyl cellulose incorporated. Gastricretention of ECS mini-tablets after oral administration torats was visually confirmed using a fluorescence imagingsystem. Because ECS mini-tablets exhibited size-dependentgastric retention, their gastric retention time wasprolonged as the release rate decreased. In the in vivoefficacy study, gastro-retentive dosage forms of ECS didnot influence the mucoprotective effect in the immediateirritation model but enhanced the effect in the delayedirritation model compared with ECS suspension. Thisfinding indicates that the duration of the mucoprotectiveeffect of ECS can be extended by the employment ofgastro-retentive dosage formulations and provides a rationalefor development of ECS gastro-retentive dosageforms.

      더보기

      참고문헌 (Reference)

      1 Kinoshita, M., "Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium" 275 : 494-501, 1995

      2 Pan, L., "Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice" 26 : 1334-1338, 2005

      3 Kinoshita, M., "Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats" 40 : 661-667, 1995

      4 Berenguer, B., "Protective and antioxidant effects of Rhizophora mangle L. against nsaid-induced gastric ulcers" 103 : 194-200, 2006

      5 Baumgartner, S., "Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium" 19 : 1084-1090, 2002

      6 Pearson, J., "Mucosal protective effects of ecabet sodium : Pepsin inhibition and interaction with mucus" 100 : 411-417, 2001

      7 Siepmann, J., "Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose(HPMC)" 48 : 139-157, 2001

      8 Ito, Y., "Metabolic fate of a new anti-ulcer drug(?)-(1R, 4aS, 10aR)-1, 2, 3, 4, 4a, 9, 10, 10a-octahydro-1, 4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate(TA-2711). I. Disposition, metabolism and protein binding in rats and dogs" 14 : 533-546, 1991

      9 Conti, S., "Matrices containing nacmc and hpmc : 2. Swelling and release mechanism study" 333 : 143-151, 2007

      10 Evangelista, S., "Influence of peripherally-administered peptides on ethanol-induced gastric ulcers in the rat" 18 : 647-649, 1987

      1 Kinoshita, M., "Roles of prostaglandins, nitric oxide and the capsaicin-sensitive sensory nerves in gastroprotection produced by ecabet sodium" 275 : 494-501, 1995

      2 Pan, L., "Roles of nitric oxide in protective effect of berberine in ethanol-induced gastric ulcer mice" 26 : 1334-1338, 2005

      3 Kinoshita, M., "Relationship between gastroprotective effect of locally acting antiulcer agent ecabet sodium and its binding to gastric mucosa in rats" 40 : 661-667, 1995

      4 Berenguer, B., "Protective and antioxidant effects of Rhizophora mangle L. against nsaid-induced gastric ulcers" 103 : 194-200, 2006

      5 Baumgartner, S., "Network structure of cellulose ethers used in pharmaceutical applications during swelling and at equilibrium" 19 : 1084-1090, 2002

      6 Pearson, J., "Mucosal protective effects of ecabet sodium : Pepsin inhibition and interaction with mucus" 100 : 411-417, 2001

      7 Siepmann, J., "Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose(HPMC)" 48 : 139-157, 2001

      8 Ito, Y., "Metabolic fate of a new anti-ulcer drug(?)-(1R, 4aS, 10aR)-1, 2, 3, 4, 4a, 9, 10, 10a-octahydro-1, 4a-dimethyl-7-(1-methylethyl)-6-sulfo-1-phenanthrenecarboxylic acid 6-sodium salt pentahydrate(TA-2711). I. Disposition, metabolism and protein binding in rats and dogs" 14 : 533-546, 1991

      9 Conti, S., "Matrices containing nacmc and hpmc : 2. Swelling and release mechanism study" 333 : 143-151, 2007

      10 Evangelista, S., "Influence of peripherally-administered peptides on ethanol-induced gastric ulcers in the rat" 18 : 647-649, 1987

      11 Oh, T.Y., "Increased susceptibility of ethanol-treated gastric mucosa to naproxen and its inhibition by DA-9601, an artemisia asiatica extract" 11 : 7450-7456, 2005

      12 Kim, H.W., "H. pylori eradication : A randomized prospective study of triple therapy with or without ecabet sodium" 14 : 908-912, 2008

      13 Sibilia, V., "Ghrelin protects against ethanol-induced gastric ulcers in rats : Studies on the mechanisms of action" 144 : 353-359, 2003

      14 Saphier, S., "Gastro intestinal tracking and gastric emptying of solid dosage forms in rats using X-ray imagining" 388 : 190-195, 2010

      15 Cao, Q.R., "Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen" ELSEVIER SCIENCE BV 108 : 351-361, 2005

      16 Brzozowski, T., "Exogenous and endogenous ghrelin in gastroprotection against stress-induced gastric damage" 120 : 39-51, 2004

      17 Adachi, K., "Efficacy of ecabet sodium for Helicobacter pylori eradication triple therapy in comparison with a lansoprazole-based regimen" 15 : 1187-1191, 2001

      18 Ito, Y., "Effects of the new anti-ulcer drug ecabet sodium(TA-2711)on pepsin activity. II : Interaction with substrate protein" 62 : 175-181, 1993

      19 Onoda, Y., "Effects of the new anti-ulcer agent 12-sulfodehydroabietic acid monosodium salt on duodenal alkaline secretion in rats" 40 : 576-578, 1990

      20 Kinoshita, M., "Effects of ecabet sodium(TA-2711), a new antiulcer agent, on gastrointestinal mucosal prostanoid production and morphology in rats" 16 : 1220-1225, 1993

      21 De Barros, M.P., "Effect of brazilian green propolis on experimental gastric ulcers in rats" 110 : 567-571, 2007

      22 Kinoshita, M., "Ecabet sodium, a novel locallyacting anti-ulcer agent, protects the integrity of the gastric mucosal gel layer from pepsin-induced disruption in the rat" 13 : 687-694, 1999

      23 Ito, Y., "Ecabet sodium, a locally acting antiulcer drug, inhibits urease activity of Helicobacter pylori" 345 : 193-198, 1998

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2023 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2020-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2004-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2001-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      1998-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 1.96 0.2 1.44
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      1.07 0.87 0.439 0.05
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼